Rufinamide

Rufinamide

SCHEMBL20769779

NC(=O)c1cn(Cc2c(F)cccc2F)nn1.NC(=O)c1cn(Cc2c(F)cccc2F)nn1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A

The experimentally established mechanism targets of Rufinamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CA5A P35218 1/20 1.00
KLKB1 P03952 2/20 0.54
CYP2C19 P33261 1/20 0.52
SCD O00767 1/20 0.51
ALDH1A1 P00352 3/20 0.50
LMNA P02545 2/20 0.50
KDM1A O60341 1/20 0.41
GRM2 Q14416 3/20 0.41
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PRSS12 P56730 1/20 0.39
TGM2 P21980 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
MARK4 Q96L34 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rufinamide SCHEMBL230448 1.00 CA5A (1.00) CA5AKLKB1CYP2C19SCDALDH1A1
Rufinamide SCHEMBL17372728 0.99 CA5A (0.97) CA5AKLKB1CYP2C19SCDALDH1A1
Rufinamide SCHEMBL2594153 0.93 CA5A (0.87) CA5AKLKB1CYP2C19SCDALDH1A1
SCHEMBL9857399 0.91 CA5A (0.82) CA5AKLKB1CYP2C19SCDALDH1A1
SCHEMBL15699133 0.91 CA5A (0.82) CA5AKLKB1CYP2C19SCDALDH1A1
SCHEMBL460913 0.87 CA5A (0.76) CA5AKLKB1CYP2C19ALDH1A1LMNA
SCHEMBL15838652 0.86 CA5A (0.75) CA5AKLKB1CYP2C19ALDH1A1LMNA
SCHEMBL6738882 0.85 CA5A (0.74) CA5AKLKB1CYP2C19ALDH1A1LMNA
SCHEMBL460954 0.85 CA5A (0.74) CA5AKLKB1CYP2C19ALDH1A1LMNA
SCHEMBL9857834 0.85 CA5A (0.73) CA5AKLKB1CYP2C19SCDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3675838-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS Puretecch LYT, Inc. (US) 2020-07-08 EP disclosed
WO-2019046491-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS ARIYA THERAPEUTICS, INC. (US) 2019-03-07 WO disclosed